Company intelligence / Profile preview

VisionCare Ophthalmic Technologies

Saratoga, California, USAvisioncaredirect.com ↗

Ownership: Private
Development stage: Commercial

Overview

VisionCare Ophthalmic Technologies developed the first FDA-recommended implantable miniature telescope for end-stage AMD. The device improves central vision by projecting enlarged images onto healthy parts of the retina. It has received both FDA approval and CE Mark in Europe. Clinical results show significant improvement in quality of life and visual function for patients with untreatable advanced AMD.

Therapeutic areas: Ophthalmology
Modalities: DeviceVisual prosthetic deviceImplantable ophthalmic device
Industry: Implantable Medical Devices

Partnerships

Not specifically listed; may include clinical sites and distribution partners globally.

Beyond the preview

Go deeper on VisionCare Ophthalmic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VisionCare Ophthalmic Technologies.

Explore the full profile